{"cursor":"31108","size":15,"audio":[],"currentlang":"en","article":"{{multiple issues|\n\n\n}}\n\n'Cancer immunotherapy' is the use of the immune system to reject cancer. The\nmain premise is stimulating the patient's immune system to attack the malignant\ntumor cells that are responsible for the disease. This can be either through\nimmunization of the patient (e.g., by administering a cancer vaccine, such as\nDendreon's Provenge), in which case the patient's own immune system is trained\nto recognize tumor cells as targets to be destroyed, or through the\nadministration of therapeutic antibodies as drugs, in which case the patient's\nimmune system is recruited to destroy tumor cells by the therapeutic antibodies.\nCell based immunotherapy is another major entity of cancer immunotherapy. This\ninvolves immune cells such as the Natural killer Cells (NK cells), Lymphokine\nActivated killer cell(LAK), Cytotoxic T Lymphocytes(CTLs), Dendritic Cells (DC),\netc., which are either activated in vivo by administering certain cytokines such\nas Interleukins or they are isolated, enriched and transfused to the patient to\nfight against cancer.\n\nSince the immune system responds to the environmental factors it encounters on\nthe basis of discrimination between self and non-self, many kinds of tumor\ncells that arise as a result of the onset of cancer are more or less tolerated\nby the patient's own immune system since the tumor cells are essentially the\npatient's own cells that are growing, dividing and spreading without proper\nregulatory control.\n\nIn spite of this fact, however, many kinds of tumor cells display unusual\nantigens that are either inappropriate for the cell type and/or its environment,\nor are only normally present during the organisms' development (e.g. fetal\nantigens). Examples of such antigens include the glycosphingolipid GD2, a\ndisialoganglioside that is normally only expressed at a significant level on the\nouter surface membranes of neuronal cells, where its exposure to the immune\nsystem is limited by the bloodâbrain barrier. GD2 is expressed on the surfaces\nof a wide range of tumor cells including neuroblastoma, medulloblastomas,\nastrocytomas, melanomas, small-cell lung cancer, osteosarcomas and other soft\ntissue sarcomas. GD2 is thus a convenient tumor-specific target for\nimmunotherapies.\n\nOther kinds of tumor cells display cell surface receptors that are rare or\nabsent on the surfaces of healthy cells, and which are responsible for\nactivating cellular signal transduction pathways that cause the unregulated\ngrowth and division of the tumor cell. Examples include ErbB2, a constitutively\nactive cell surface receptor that is produced at abnormally high levels on the\nsurface of breast cancer tumor cells.\n\nThe use of some agents can lead to the re-activation of latent tuberculosis (TB)\nand this must be assessed for before those agents are used therapeutically.[htt-\np://www.thedoctorschannel.com/go/reuters/2153.html][http://www.brit-\nthoracic.org.uk/guidelines/tuberculosis-guidelines.aspx]\n","linknr":808,"url":"Cancer_immunotherapy","recorded":1376425769,"links":["/w/index.php?title=Cancer_immunotherapy&action=edit","/w/index.php?title=Cancer_immunotherapy&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","http://en.wikipedia.org/wiki/Cancer_immunotherapy","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.visualEditor.viewPageTarget.noscript&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","#mw-navigation","#p-search","//upload.wikimedia.org/wikipedia/en/f/f4/Ambox_content.png","//en.wikipedia.org/w/index.php?title=Cancer_immunotherapy&action=edit","/wiki/Talk:Cancer_immunotherapy","//upload.wikimedia.org/wikipedia/en/f/f4/Ambox_content.png","/wiki/Wikipedia:Identifying_reliable_sources_(medicine)","/wiki/Wikipedia:Verifiability","//en.wikipedia.org/w/index.php?title=Cancer_immunotherapy&action=edit","/wiki/Wikipedia:Verifiability#Burden_of_evidence","/wiki/File:Rod_of_asclepius.png","//upload.wikimedia.org/wikipedia/commons/thumb/3/3d/Rod_of_asclepius.png/15px-Rod_of_asclepius.png","//upload.wikimedia.org/wikipedia/en/f/f4/Ambox_content.png","/wiki/Wikipedia:No_original_research","//en.wikipedia.org/w/index.php?title=Cancer_immunotherapy&action=edit","/wiki/Wikipedia:Verifiability","/wiki/Wikipedia:INCITE","/wiki/Immune_system","/wiki/Cancer","/wiki/Tumor","/wiki/Immunization","/wiki/Cancer_vaccine","/wiki/Provenge","/wiki/Monoclonal_antibody#Applications","/wiki/Cell_(biology)","/wiki/Cell_division","/wiki/Antigen","/wiki/Fetus","/wiki/Glycosphingolipid","/wiki/GD2","/wiki/Disialoganglioside","/wiki/Neuron","/wiki/Blood%E2%80%93brain_barrier","/wiki/Neuroblastoma","/wiki/Medulloblastoma","/wiki/Astrocytoma","/wiki/Melanoma","/wiki/Small-cell_lung_cancer","/wiki/Osteosarcoma","/wiki/Soft_tissue_sarcoma","/wiki/Cell_surface_receptor","/wiki/Signal_transduction","/wiki/ErbB2","/wiki/Breast_cancer","/wiki/Tuberculosis","http://www.thedoctorschannel.com/go/reuters/2153.html","http://www.brit-thoracic.org.uk/guidelines/tuberculosis-guidelines.aspx","#Cell_Based_immunotherapy","#Monoclonal_antibody_therapy","#Types_of_monoclonal_antibodies","#Alemtuzumab","#Bevacizumab","#Cetuximab","#Gemtuzumab_ozogamicin","#Rituximab","#Trastuzumab","#Radioimmunotherapy","#Ibritumomab_tiuxetan","#Tositumomab.2Fiodine_.28131I.29_tositumomab_regimen","#Advances_in_immunotherapy","#Immune_checkpoint_blockade","#Natural_products","#Public_awareness","#See_also","#External_links","#References","/w/index.php?title=Cancer_immunotherapy&action=edit&section=1","/w/index.php?title=Cancer_immunotherapy&veaction=edit&section=1","/wiki/Autologous_immune_enhancement_therapy","#cite_note-1","/wiki/MRNA","/wiki/CureVac","#cite_note-2","#cite_note-3","/w/index.php?title=Cancer_immunotherapy&action=edit&section=2","/w/index.php?title=Cancer_immunotherapy&veaction=edit&section=2","/wiki/Monoclonal_antibody_therapy","/wiki/Antibody","/wiki/Adaptive_immune_system","/wiki/Monoclonal_antibody","/w/index.php?title=Cancer_immunotherapy&action=edit&section=3","/w/index.php?title=Cancer_immunotherapy&veaction=edit&section=3","/wiki/Food_and_Drug_Administration_(United_States)","#cite_note-Waldmann-4","/wiki/Alemtuzumab","/wiki/CD52","/wiki/Chronic_lymphocytic_leukemia","/wiki/Bevacizumab","/wiki/Vascular_endothelial_growth_factor","/wiki/Colorectal_cancer","/wiki/Brentuximab_vedotin","/wiki/CD30","/wiki/Hodgkin_lymphoma","/wiki/Anaplastic_large-cell_lymphoma","/wiki/Cetuximab","/wiki/Epidermal_growth_factor_receptor","/wiki/Colorectal_cancer","/wiki/Gemtuzumab_ozogamicin","/wiki/CD33","/wiki/Acute_myelogenous_leukemia","/wiki/Calicheamicin","/wiki/Ibritumomab_tiuxetan","/wiki/CD20","/wiki/Non-Hodgkin_lymphoma","/wiki/Yttrium","/wiki/Indium","/wiki/Panitumumab","/wiki/Epidermal_growth_factor_receptor","/wiki/Colorectal_cancer","/wiki/Rituximab","/wiki/CD20","/wiki/Non-Hodgkin_lymphoma","/wiki/Trastuzumab","/wiki/ErbB2","/wiki/Breast_cancer","/w/index.php?title=Cancer_immunotherapy&action=edit&section=4","/w/index.php?title=Cancer_immunotherapy&veaction=edit&section=4","/wiki/Alemtuzumab","/wiki/CD52","/wiki/Chronic_lymphocytic_leukemia","/wiki/Leukaemia","#cite_note-5","/wiki/Lymphocyte","/wiki/Monocyte","/wiki/Complement_system","#cite_note-6","/w/index.php?title=Cancer_immunotherapy&action=edit&section=5","/w/index.php?title=Cancer_immunotherapy&veaction=edit&section=5","/wiki/Bevacizumab","/wiki/Steric","/wiki/Vascular_endothelial_growth_factor","/wiki/Receptor_(biochemistry)","/wiki/Vascular_endothelial_growth_factor","/wiki/Tumor","/wiki/Angiogenesis","/wiki/Colon_cancer","/wiki/Renal_cell_carcinoma","#cite_note-7","/w/index.php?title=Cancer_immunotherapy&action=edit&section=6","/w/index.php?title=Cancer_immunotherapy&veaction=edit&section=6","/wiki/Cetuximab","/wiki/Epidermal_growth_factor_receptor","/wiki/Ligand","/wiki/Colorectal_cancer","/wiki/Non-small_cell_lung_cancer","/wiki/Head_and_neck_cancer","#cite_note-Waldmann-4","/wiki/ABX-EGF","/wiki/EMD_72000","/wiki/Clinical_trial","/w/index.php?title=Cancer_immunotherapy&action=edit&section=7","/w/index.php?title=Cancer_immunotherapy&veaction=edit&section=7","/wiki/Gemtuzumab_ozogamicin","/wiki/CD33","/wiki/Calicheamicin","/wiki/Acute_myeloid_leukaemia","#cite_note-8","/w/index.php?title=Cancer_immunotherapy&action=edit&section=8","/w/index.php?title=Cancer_immunotherapy&veaction=edit&section=8","/wiki/Rituximab","/wiki/CD20","/wiki/Calcium","/wiki/Plasma_membrane","/wiki/B_cells","#cite_note-Janeway-9","/wiki/Cell_cycle","#cite_note-Waldmann-4","/wiki/Primate","/wiki/Lymph_node","/wiki/Bone_marrow","#cite_note-10","/w/index.php?title=Cancer_immunotherapy&action=edit&section=9","/w/index.php?title=Cancer_immunotherapy&veaction=edit&section=9","/wiki/Trastuzumab","/wiki/Epidermal_growth_factor_receptor","/wiki/HER2","/wiki/Breast_cancer","/wiki/Immunohistochemistry","/wiki/Fluorescence","/wiki/In_situ","/wiki/Nucleic_acid_hybridization","/wiki/Fluorescent_in_situ_hybridization","/wiki/PCR","/wiki/Tyrosine_kinases","/wiki/Cell_proliferation","/wiki/Differentiation_(cellular)","#cite_note-11","/wiki/Prognosis","/wiki/Hormonal_therapy","#cite_note-12","/w/index.php?title=Cancer_immunotherapy&action=edit&section=10","/w/index.php?title=Cancer_immunotherapy&veaction=edit&section=10","/wiki/Radioimmunotherapy","/wiki/Radioactive","/wiki/Lymphomas","/w/index.php?title=Cancer_immunotherapy&action=edit&section=11","/w/index.php?title=Cancer_immunotherapy&veaction=edit&section=11","/wiki/Ibritumomab_tiuxetan","/wiki/Yttrium-90","/wiki/Beta_radiation","/wiki/Half-life","/wiki/Follicular_lymphoma","#cite_note-13","/w/index.php?title=Cancer_immunotherapy&action=edit&section=12","/w/index.php?title=Cancer_immunotherapy&veaction=edit&section=12","/wiki/Tositumomab","/wiki/CD20","/wiki/Iodine","/wiki/Beta_radiation","/wiki/Gamma_radiation","#cite_note-14","/wiki/Relapse","/wiki/Follicular_lymphoma","#cite_note-15","/w/index.php?title=Cancer_immunotherapy&action=edit&section=13","/w/index.php?title=Cancer_immunotherapy&veaction=edit&section=13","/wiki/Immunosuppression","/wiki/Cytokine","/wiki/Interleukin-2","/wiki/Adverse_effect","/wiki/Toxicity","/wiki/Chimera_(protein)","/wiki/Artificial_T_cell_receptor","/wiki/Ibritumomab_tiuxetan","/wiki/Gemtuzumab_ozogamicin","/wiki/Antibody-drug_conjugate","/wiki/Endocytosis","/wiki/Disulfide_bond","/wiki/Redox","/wiki/Hydrazone","/wiki/Peptide_bond","#cite_note-16","/w/index.php?title=Cancer_immunotherapy&action=edit&section=14","/w/index.php?title=Cancer_immunotherapy&veaction=edit&section=14","/wiki/PD-L1","/wiki/Renal_cell_carcinoma","#cite_note-pmid15569934-17","/wiki/Ovarian_cancer","#cite_note-pmid17360651-18","/w/index.php?title=PD-L1_blocker&action=edit&redlink=1","/wiki/Immune_checkpoint_blockade","//en.wikipedia.org/w/index.php?title=Cancer_immunotherapy&action=edit","#cite_note-19","/wiki/CTLA-4","#cite_note-Pardoll2012-20","/wiki/Ipilimumab","/w/index.php?title=Cancer_immunotherapy&action=edit&section=15","/w/index.php?title=Cancer_immunotherapy&veaction=edit&section=15","/wiki/Medicinal_mushrooms","/wiki/Reishi","/wiki/Agaricus_subrufescens","/wiki/Agaricus_subrufescens","/wiki/Natural_killer_cells","#cite_note-STUDIES_ON_THE_EFFECT_OF_LENTINAN_ON_HUMAN_IMMUNE_SYSTEM._II._IN_VIVO_EFFECT_ON_NK_ACTIVITY.2C_MLR_INDUCED_KILLER_ACTIVITY_AND_PHA_INDUCED_BLASTIC_RESPONSE_OF_LYMPHOCYTES_IN_CANCER_PATIENTS.-21","/wiki/Agaricus_subrufescens","/wiki/Beta-glucans","/wiki/Macrophages","#cite_note-b-1.2C3-glucan_reduces_growth_of_Mycobacterium_bovis_in_macrophage_cultures.-22","/wiki/Medicinal_mushrooms","/wiki/Polysaccharide","/wiki/Beta-glucans","/wiki/Innate_immune_system","/wiki/Macrophage","/wiki/NK_cells","/wiki/T_cells","/wiki/Cytokines","/wiki/Complement_Receptor_3","/wiki/CD18","/wiki/Cell_receptor","#cite_note-pmid15084502-23","/wiki/Lentinan","/wiki/Shiitake","/wiki/Polysaccharide-K","/wiki/Trametes_versicolor","/wiki/Japan","#cite_note-psk-24","/wiki/Ministry_of_Health,_Labour_and_Welfare_(Japan)","/wiki/Polysaccharide-K","/wiki/Australia","/w/index.php?title=MC-S&action=edit&redlink=1","/w/index.php?title=Cancer_immunotherapy&action=edit&section=16","/w/index.php?title=Cancer_immunotherapy&veaction=edit&section=16","#cite_note-25","#cite_note-26","#cite_note-27","#cite_note-28","#cite_note-29","/w/index.php?title=Cancer_immunotherapy&action=edit&section=17","/w/index.php?title=Cancer_immunotherapy&veaction=edit&section=17","/wiki/5T4","/wiki/Cancer_vaccine","/wiki/Immunotherapy","/wiki/Coley%27s_Toxins","/wiki/Tumor_antigen","/w/index.php?title=Cancer_immunotherapy&action=edit&section=18","/w/index.php?title=Cancer_immunotherapy&veaction=edit&section=18","http://www.cancerresearch.org/cancer-immunotherapy","http://www.immunotreatment.org","http://www.c-imt.org","http://www.sitcancer.org","http://www.cancerresearch.org/programs/research/Cancer-Immunotherapy-Consortium","http://www.parenteaubc.com/alliance/index.html","http://www.fightcancerwithimmunotherapy.com","/w/index.php?title=Cancer_immunotherapy&action=edit&section=19","/w/index.php?title=Cancer_immunotherapy&veaction=edit&section=19","#cite_ref-1","http://clinicaltrials.gov/ct2/show/NCT01422850","/wiki/Help:CS1_errors#wikilink_in_url","#cite_ref-2","http://www.ncbi.nlm.nih.gov/pubmed/10602021","#cite_ref-3","http://clinicaltrials.gov/ct2/show/NCT01817738?term=curevac&rank=2","#cite_ref-Waldmann_4-0","#cite_ref-Waldmann_4-1","#cite_ref-Waldmann_4-2","http://www.nature.com/cgi-taf/DynaPage.taf?file=/nm/journal/v9/n3/full/nm0303-269.html&filetype=pdf","/wiki/Digital_object_identifier","http://dx.doi.org/10.1038%2Fnm0303-269","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/12612576","#cite_ref-5","http://www.asheducationbook.org/cgi/content/full/2004/1/163","#cite_ref-6","/wiki/Digital_object_identifier","http://dx.doi.org/10.1200%2FJCO.20.1.205","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/11773171","/wiki/Help:CS1_errors#displayauthors","#cite_ref-7","/wiki/Digital_object_identifier","http://dx.doi.org/10.1056%2FNEJMoa032691","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/15175435","/wiki/Help:CS1_errors#displayauthors","#cite_ref-8","#cite_ref-Janeway_9-0","/wiki/Charles_Janeway","http://www.ncbi.nlm.nih.gov/books/bv.fcgi?call=bv.View..ShowTOC&rid=imm.TOC&depth=10","/wiki/International_Standard_Book_Number","/wiki/Special:BookSources/0-8153-4101-6","#cite_ref-10","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/7506951","/wiki/Help:CS1_errors#displayauthors","#cite_ref-11","/wiki/Digital_object_identifier","http://dx.doi.org/10.1038%2Fsj.onc.1202698","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/10376526","#cite_ref-12","/wiki/Digital_object_identifier","http://dx.doi.org/10.1126%2Fscience.2470152","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/2470152","/wiki/Help:CS1_errors#displayauthors","#cite_ref-13","#cite_ref-14","http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1237157","/wiki/Digital_object_identifier","http://dx.doi.org/10.3121%2Fcmr.3.3.157","/wiki/PubMed_Central","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1237157","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/16160070","#cite_ref-15","/wiki/Digital_object_identifier","http://dx.doi.org/10.1056%2FNEJMoa041511","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/15689582","/wiki/Help:CS1_errors#displayauthors","#cite_ref-16","http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1298180","/wiki/Digital_object_identifier","http://dx.doi.org/10.1073%2Fpnas.0509035102","/wiki/PubMed_Central","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1298180","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/16322102","#cite_ref-pmid15569934_17-0","http://www.ncbi.nlm.nih.gov/pmc/articles/PMC534606","/wiki/Digital_object_identifier","http://dx.doi.org/10.1073%2Fpnas.0406351101","/wiki/PubMed_Central","//www.ncbi.nlm.nih.gov/pmc/articles/PMC534606","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/15569934","#cite_ref-pmid17360651_18-0","http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1805580","/wiki/Digital_object_identifier","http://dx.doi.org/10.1073%2Fpnas.0611533104","/wiki/PubMed_Central","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1805580","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/17360651","#cite_ref-19","http://www.medpagetoday.com/MeetingCoverage/AACR/38388?utm_content=&utm_source=WC&xid=NL_DHE_2013-04-11&eun=g431352d0r&mu_id=5529190","#cite_ref-Pardoll2012_20-0","http://www.ncbi.nlm.nih.gov/pubmed/22437870","/wiki/Help:CS1_errors#parameter_ignored","#cite_ref-STUDIES_ON_THE_EFFECT_OF_LENTINAN_ON_HUMAN_IMMUNE_SYSTEM._II._IN_VIVO_EFFECT_ON_NK_ACTIVITY.2C_MLR_INDUCED_KILLER_ACTIVITY_AND_PHA_INDUCED_BLASTIC_RESPONSE_OF_LYMPHOCYTES_IN_CANCER_PATIENTS._21-0","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/6225393","#cite_ref-b-1.2C3-glucan_reduces_growth_of_Mycobacterium_bovis_in_macrophage_cultures._22-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1111%2Fj.1574-695X.2002.tb00570.x","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/11985967","#cite_ref-pmid15084502_23-0","http://cmr.asm.org/cgi/pmidlookup?view=long&pmid=15084502","/wiki/Digital_object_identifier","http://dx.doi.org/10.1128%2FCMR.17.2.281-310.2004","/wiki/International_Standard_Serial_Number","//www.worldcat.org/issn/0893-8512","/wiki/PubMed_Central","//www.ncbi.nlm.nih.gov/pmc/articles/PMC387410","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/15084502","//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/15084502&action=edit&editintro=Template:Cite_pmid/editintro2","#cite_ref-psk_24-0","http://www.cancer.org/docroot/ETO/content/ETO_5_3X_Coriolous_Versicolor.asp","#cite_ref-25","http://www.nytimes.com/2013/05/16/business/melanoma-treatment-harnesses-immune-system-to-combat-cancer-cells.html","#cite_ref-26","http://online.wsj.com/article/SB10001424127887323398204578485401089823868.html","#cite_ref-27","http://www.cnn.com/2013/05/16/health/cancer-research/index.html","#cite_ref-28","http://www.nytimes.com/2012/12/10/health/a-breakthrough-against-leukemia-using-altered-t-cells.html?pagewanted=all","#cite_ref-29","http://www.cancerresearch.org/news-publications/news-at-cri/2013/may/cancer-research-institute-announces-june-cancer-immunotherapy-awareness-month","/wiki/Template:Tumors","/wiki/Template_talk:Tumors","//en.wikipedia.org/w/index.php?title=Template:Tumors&action=edit","/wiki/Pathology","/wiki/Tumor","/wiki/Neoplasm","/wiki/Cancer","/wiki/Oncology","/wiki/ICD-10_Chapter_III:_Diseases_of_the_blood_and_blood-forming_organs,_and_certain_disorders_involving_the_immune_mechanism","/wiki/List_of_ICD-9_codes_140%E2%80%93239:_neoplasms","/wiki/Benign_tumor","/wiki/Hyperplasia","/wiki/Cyst","/wiki/Pseudocyst","/wiki/Hamartoma","/wiki/Dysplasia","/wiki/Carcinoma_in_situ","/wiki/Cancer","/wiki/Metastasis","/wiki/Head_and_neck_cancer","/wiki/Oral_cancer","/wiki/Nasopharyngeal_carcinoma","/wiki/Digestive_system_neoplasm","/wiki/Respiratory_tract_neoplasm","/wiki/Bone_tumor","/wiki/Skin_cancer","/wiki/Leukemia","/wiki/Urogenital_neoplasm","/wiki/Nervous_system_neoplasm","/wiki/Endocrine_gland_neoplasm","/wiki/Carcinoma","/wiki/Sarcoma","/wiki/Blastoma","/wiki/Papilloma","/wiki/Adenoma","/wiki/Precancerous_condition","/wiki/Paraneoplastic_syndrome","/wiki/Cancer_staging","/wiki/Grading_(tumors)","/wiki/TNM_staging_system","/wiki/Ann_Arbor_staging","/wiki/Prostate_cancer_staging","/wiki/Gleason_Grading_System","/wiki/Dukes_classification","/wiki/Carcinogenesis","/wiki/Cancer_cell","/wiki/Carcinogen","/wiki/Tumor_suppressor_gene","/wiki/Oncogene","/wiki/Clonally_transmissible_cancer","/wiki/Oncovirus","/wiki/Cancer_bacteria","/wiki/Cancer_research","/wiki/List_of_oncology-related_terms","/wiki/History_of_cancer","/wiki/Cancer_pain","/wiki/Template:Medicine_navs","/wiki/Neoplasm","/wiki/Template:Tumor_suppressor_genes_and_oncogenes","/wiki/Template:Tumor_markers","/wiki/Template:Tumors","/wiki/Template:Eponymous_medical_signs_for_oncology","/wiki/Template:Paraneoplastic_syndromes","/wiki/ATC_code_L","/wiki/Template:Intracellular_chemotherapeutic_agents","/wiki/Template:Extracellular_chemotherapeutic_agents","/wiki/Template:Detoxifying_agents_for_antineoplastic_treatment","/wiki/Template:Intracellular_chemotherapeutic_agents","/wiki/Template_talk:Intracellular_chemotherapeutic_agents","//en.wikipedia.org/w/index.php?title=Template:Intracellular_chemotherapeutic_agents&action=edit","/wiki/Chemotherapy_(oncology)","/wiki/Antineoplastic","/wiki/ATC_code_L01","/wiki/Spindle_poison","/wiki/Mitotic_inhibitor","/wiki/M_phase","/wiki/Microtubule","/wiki/Catharanthus#Vinca_alkaloids","/wiki/Vinblastine","/wiki/Vincristine","/wiki/Vinflunine","/wiki/Vindesine","/wiki/Vinorelbine","/wiki/Taxane","/wiki/Cabazitaxel","/wiki/Docetaxel","/wiki/Larotaxel","/wiki/Ortataxel","/wiki/Paclitaxel","/wiki/Tesetaxel","/wiki/Epothilone","/wiki/Ixabepilone","/wiki/DNA_replication","/wiki/Antimetabolite","/wiki/S_phase","/wiki/Antifolate","/wiki/Dihydrofolate_reductase_inhibitor","/wiki/Aminopterin","/wiki/Methotrexate","/wiki/Pemetrexed","/wiki/Pralatrexate","/wiki/Thymidylate_synthase_inhibitor","/wiki/Raltitrexed","/wiki/Pemetrexed","/wiki/Purine_analogue","/wiki/Adenosine_deaminase_inhibitor","/wiki/Pentostatin","/wiki/Halogenated","/wiki/Ribonucleotide_reductase_inhibitor","/wiki/Cladribine","/wiki/Clofarabine","/wiki/Fludarabine","/wiki/Nelarabine","/wiki/Thiopurine","/wiki/Tioguanine","/wiki/Mercaptopurine","/wiki/Pyrimidine_analogue","/wiki/Thymidylate_synthase_inhibitor","/wiki/Fluorouracil","/wiki/Capecitabine","/wiki/Tegafur","/wiki/Carmofur","/wiki/Floxuridine","/wiki/DNA_polymerase_inhibitor","/wiki/Cytarabine","/wiki/Ribonucleotide_reductase_inhibitor","/wiki/Gemcitabine","/wiki/Hypomethylating_agent","/wiki/Azacitidine","/wiki/Decitabine","/wiki/Deoxyribonucleotide","/wiki/Ribonucleotide_reductase_inhibitor","/wiki/Hydroxycarbamide","/wiki/Topoisomerase_inhibitor","/wiki/S_phase","/wiki/Topoisomerase_I#Inhibition","/wiki/Camptotheca","/wiki/Camptothecin","/wiki/Topotecan","/wiki/Irinotecan","/wiki/Rubitecan","/wiki/Belotecan","/wiki/Topoisomerase_II#Inhibition","/wiki/American_Mayapple","/wiki/Etoposide","/wiki/Teniposide","/wiki/Topoisomerase_II#Inhibition","/wiki/Intercalation_(chemistry)","/wiki/Anthracycline","/wiki/Aclarubicin","/wiki/Daunorubicin","/wiki/Doxorubicin","/wiki/Epirubicin","/wiki/Idarubicin","/wiki/Amrubicin","/wiki/Pirarubicin","/wiki/Valrubicin","/wiki/Zorubicin","/wiki/Anthracenedione","/wiki/Mitoxantrone","/wiki/Pixantrone","/wiki/Crosslinking_of_DNA","/wiki/Cell-cycle_nonspecific_antineoplastic_agents","/wiki/Alkylating_antineoplastic_agent","/wiki/Nitrogen_mustard","/wiki/Mechlorethamine","/wiki/Cyclophosphamide","/wiki/Ifosfamide","/wiki/Trofosfamide","/wiki/Chlorambucil","/wiki/Melphalan","/wiki/Prednimustine","/wiki/Bendamustine","/wiki/Uramustine","/wiki/Estramustine","/wiki/Nitrosourea","/wiki/Carmustine","/wiki/Lomustine","/wiki/Semustine","/wiki/Fotemustine","/wiki/Nimustine","/wiki/Ranimustine","/wiki/Streptozotocin","/wiki/Alkyl_sulfonate","/wiki/Busulfan","/wiki/Mannosulfan","/wiki/Treosulfan","/wiki/Aziridine","/wiki/Carboquone","/wiki/ThioTEPA","/wiki/Triaziquone","/wiki/Triethylenemelamine","/wiki/Platinum-based_antineoplastic","/wiki/Carboplatin","/wiki/Cisplatin","/wiki/Nedaplatin","/wiki/Oxaliplatin","/wiki/Satraplatin","/wiki/Alkylating_antineoplastic_agent#Nonclassical","/wiki/Hydrazine","/wiki/Procarbazine","/wiki/Triazene","/wiki/Dacarbazine","/wiki/Temozolomide","/wiki/Altretamine","/wiki/Mitobronitol","/wiki/Pipobroman","/wiki/Intercalation_(chemistry)","/wiki/Streptomyces","/wiki/Actinomycin","/wiki/Bleomycin","/wiki/Mitomycin","/wiki/Plicamycin","/wiki/Photosensitizer","/wiki/Photodynamic_therapy","/wiki/D-Aminolevulinic_acid","/wiki/Methyl_aminolevulinate","/wiki/Efaproxiral","/wiki/Porphyrin","/wiki/Porfimer_sodium","/wiki/Talaporfin","/wiki/Temoporfin","/wiki/Verteporfin","/wiki/Enzyme_inhibitor","/wiki/Farnesyltransferase_inhibitor","/wiki/Tipifarnib","/wiki/Cyclin-dependent_kinase","/wiki/Protein_kinase_inhibitor","/wiki/Alvocidib","/wiki/Seliciclib","/wiki/Proteasome_inhibitor","/wiki/Bortezomib","/wiki/Carfilzomib","/wiki/Phosphodiesterase_inhibitor","/wiki/Anagrelide","/wiki/IMP_dehydrogenase","/wiki/Tiazofurin","/wiki/Lipoxygenase_inhibitor","/wiki/Masoprocol","/wiki/PARP_inhibitor","/wiki/Olaparib","/wiki/Histone_deacetylase_inhibitor","/wiki/Panobinostat","/wiki/Vorinostat","/wiki/Romidepsin","/wiki/Receptor_antagonist","/wiki/Endothelin_receptor_antagonist","/wiki/Atrasentan","/wiki/Retinoid_X_receptor","/wiki/Bexarotene","/wiki/Sex_steroid","/wiki/Testolactone","/wiki/Amsacrine","/wiki/Trabectedin","/wiki/Retinoid","/wiki/Alitretinoin","/wiki/Tretinoin","/wiki/Arsenic_trioxide","/wiki/Asparagine","/wiki/Asparaginase","/wiki/Pegaspargase","/wiki/Celecoxib","/wiki/Demecolcine","/wiki/Elesclomol","/wiki/Elsamitrucin","/wiki/Etoglucid","/wiki/Lonidamine","/wiki/Lucanthone","/wiki/Mitoguazone","/wiki/Mitotane","/wiki/Oblimersen","/wiki/Omacetaxine_mepesuccinate","/wiki/Eribulin","/wiki/List_of_World_Health_Organization_Essential_Medicines","/wiki/List_of_withdrawn_drugs","/wiki/Clinical_trial","/wiki/Clinical_trial#Phase_III","/wiki/Clinical_trial#Phase_II","/wiki/Template:Medicine_navs","/wiki/Neoplasm","/wiki/Template:Tumor_suppressor_genes_and_oncogenes","/wiki/Template:Tumor_markers","/wiki/Template:Tumors","/wiki/Template:Eponymous_medical_signs_for_oncology","/wiki/Template:Paraneoplastic_syndromes","/wiki/ATC_code_L","/wiki/Template:Intracellular_chemotherapeutic_agents","/wiki/Template:Extracellular_chemotherapeutic_agents","/wiki/Template:Detoxifying_agents_for_antineoplastic_treatment","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=Cancer_immunotherapy&oldid=563932433","/wiki/Help:Category","/wiki/Category:Immune_system","/wiki/Category:Monoclonal_antibodies_for_tumors","/wiki/Category:Cancer_treatments","/wiki/Category:Pages_with_citations_having_wikilinks_embedded_in_URL_titles","/wiki/Category:Pages_using_citations_with_old-style_implicit_et_al.","/wiki/Category:Pages_with_citations_using_unsupported_parameters","/wiki/Category:Articles_needing_additional_medical_references_from_March_2013","/wiki/Category:All_articles_needing_additional_references","/wiki/Category:Articles_that_may_contain_original_research_from_March_2013","/wiki/Category:All_articles_that_may_contain_original_research","/wiki/Category:Articles_containing_potentially_dated_statements_from_April_2013","/wiki/Category:All_articles_containing_potentially_dated_statements","/w/index.php?title=Special:UserLogin&returnto=Cancer+immunotherapy&type=signup","/w/index.php?title=Special:UserLogin&returnto=Cancer+immunotherapy","/wiki/Cancer_immunotherapy","/wiki/Talk:Cancer_immunotherapy","#","/wiki/Cancer_immunotherapy","/w/index.php?title=Cancer_immunotherapy&action=edit","/w/index.php?title=Cancer_immunotherapy&veaction=edit","/w/index.php?title=Cancer_immunotherapy&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Cancer_immunotherapy","/wiki/Special:RecentChangesLinked/Cancer_immunotherapy","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Cancer_immunotherapy&oldid=563932433","/w/index.php?title=Cancer_immunotherapy&action=info","//www.wikidata.org/wiki/Q2012719","/w/index.php?title=Special:Cite&page=Cancer_immunotherapy&id=563932433","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Cancer+immunotherapy","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Cancer+immunotherapy&oldid=563932433&writer=rl","/w/index.php?title=Cancer_immunotherapy&printable=yes","//cs.wikipedia.org/wiki/Biologick%C3%A1_l%C3%A9%C4%8Dba_n%C3%A1dorov%C3%BDch_onemocn%C4%9Bn%C3%AD","//de.wikipedia.org/wiki/Krebsimmuntherapie","//fr.wikipedia.org/wiki/Immunologie_des_tumeurs","//it.wikipedia.org/wiki/Terapia_con_anticorpi_monoclonali","//lt.wikipedia.org/wiki/Imunoterapija","//sl.wikipedia.org/wiki/Biolo%C5%A1ka_zdravila","//fi.wikipedia.org/wiki/Monoklonaalinen_vasta-aineterapia","//te.wikipedia.org/wiki/%E0%B0%AE%E0%B1%8B%E0%B0%A8%E0%B1%8B%E0%B0%95%E0%B1%8D%E0%B0%B2%E0%B1%8B%E0%B0%A8%E0%B0%B2%E0%B1%8D_%E0%B0%AF%E0%B0%BE%E0%B0%82%E0%B0%9F%E0%B1%80%E0%B0%AC%E0%B0%BE%E0%B0%A1%E0%B1%80_%E0%B0%A5%E0%B1%86%E0%B0%B0%E0%B0%AA%E0%B1%80","//tr.wikipedia.org/wiki/Kanser_imm%C3%BCnoterapisi","#","//www.wikidata.org/wiki/Q2012719#sitelinks-wikipedia","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/Cancer_immunotherapy","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":["biochemistry","cellular","japan","united_states","biology","protein"],"pdf":["http://www.nature.com/cgi-taf/DynaPage.taf?file=/nm/journal/v9/n3/full/nm0303-269.html&filetype=pdf"],"categories":["Immune system","Monoclonal antibodies for tumors","Cancer treatments"],"headings":["Cell Based immunotherapy","Monoclonal antibody therapy","Types of monoclonal antibodies","Radioimmunotherapy","Advances in immunotherapy","Natural products","Public awareness","See also","External links","References"],"image":["//upload.wikimedia.org/wikipedia/en/f/f4/Ambox_content.png","//upload.wikimedia.org/wikipedia/en/f/f4/Ambox_content.png","//upload.wikimedia.org/wikipedia/commons/thumb/3/3d/Rod_of_asclepius.png/15px-Rod_of_asclepius.png","//upload.wikimedia.org/wikipedia/en/f/f4/Ambox_content.png","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[["cell","biology"],["food_and_drug_administration","united_states"],["receptor","biochemistry"],["differentiation","cellular"],["chimera","protein"],["ministry_of_health,_labour_and_welfare","japan"]],"members":["receptor","differentiation","food_and_drug_administration","cell","chimera"],"related":["Immune_system","Cancer","Tumor","Immunization","Cancer_vaccine","Provenge","Cell_(biology)","Cell_division","Antigen","Fetus","Glycosphingolipid","GD2","Disialoganglioside","Neuron","Blood–brain_barrier","Neuroblastoma","Medulloblastoma","Astrocytoma","Melanoma","Small-cell_lung_cancer","Osteosarcoma","Soft_tissue_sarcoma","Cell_surface_receptor","Signal_transduction","ErbB2","Breast_cancer","Tuberculosis","Autologous_immune_enhancement_therapy","MRNA","CureVac","Antibody","Adaptive_immune_system","Monoclonal_antibody","Food_and_Drug_Administration_(United_States)","Alemtuzumab","CD52","Chronic_lymphocytic_leukemia","Bevacizumab","Vascular_endothelial_growth_factor","Colorectal_cancer","Brentuximab_vedotin","CD30","Hodgkin_lymphoma","Anaplastic_large-cell_lymphoma","Cetuximab","Epidermal_growth_factor_receptor","Colorectal_cancer","Gemtuzumab_ozogamicin","CD33","Acute_myelogenous_leukemia","Calicheamicin","Ibritumomab_tiuxetan","CD20","Non-Hodgkin_lymphoma","Yttrium","Indium","Panitumumab","Epidermal_growth_factor_receptor","Colorectal_cancer","Rituximab","CD20","Non-Hodgkin_lymphoma","Trastuzumab","ErbB2","Breast_cancer","Alemtuzumab","CD52","Chronic_lymphocytic_leukemia","Leukaemia","Lymphocyte","Monocyte","Complement_system","Bevacizumab","Steric","Vascular_endothelial_growth_factor","Receptor_(biochemistry)","Vascular_endothelial_growth_factor","Tumor","Angiogenesis","Colon_cancer","Renal_cell_carcinoma","Cetuximab","Epidermal_growth_factor_receptor","Ligand","Colorectal_cancer","Non-small_cell_lung_cancer","Head_and_neck_cancer","ABX-EGF","EMD_72000","Clinical_trial","Gemtuzumab_ozogamicin","CD33","Calicheamicin","Acute_myeloid_leukaemia","Rituximab","CD20","Calcium","Plasma_membrane","B_cells","Cell_cycle","Primate","Lymph_node","Bone_marrow","Trastuzumab","Epidermal_growth_factor_receptor","HER2","Breast_cancer","Immunohistochemistry","Fluorescence","In_situ","Nucleic_acid_hybridization","Fluorescent_in_situ_hybridization","PCR","Tyrosine_kinases","Cell_proliferation","Differentiation_(cellular)","Prognosis","Hormonal_therapy","Radioimmunotherapy","Radioactive","Lymphomas","Ibritumomab_tiuxetan","Yttrium-90","Beta_radiation","Half-life","Follicular_lymphoma","Tositumomab","CD20","Iodine","Beta_radiation","Gamma_radiation","Relapse","Follicular_lymphoma","Immunosuppression","Cytokine","Interleukin-2","Adverse_effect","Toxicity","Chimera_(protein)","Artificial_T_cell_receptor","Ibritumomab_tiuxetan","Gemtuzumab_ozogamicin","Antibody-drug_conjugate","Endocytosis","Disulfide_bond","Redox","Hydrazone","Peptide_bond","PD-L1","Renal_cell_carcinoma","Ovarian_cancer","PD-L1_blocker","Immune_checkpoint_blockade","CTLA-4","Ipilimumab","Reishi","Natural_killer_cells","Beta-glucans","Macrophages","Medicinal_mushrooms","Polysaccharide","Beta-glucans","Innate_immune_system","Macrophage","NK_cells","T_cells","Cytokines","Complement_Receptor_3","CD18","Cell_receptor","Lentinan","Shiitake","Polysaccharide-K","Japan","Ministry_of_Health,_Labour_and_Welfare_(Japan)","Polysaccharide-K","Australia","MC-S","5T4","Cancer_vaccine","Immunotherapy","Coley's_Toxins","Tumor_antigen"]}